Article Text
Statistics from Altmetric.com
Joshua Crites and Eric Kodish focuses on unrealistic optimism as a significant factor in parental decisions when consenting for their child to participate in a phase I study.1 They define unrealistic optimism as ‘when people perceive their own personal outcomes as being more positive than those of other people in similar circumstances’. Faced with the dire circumstances of relapsed malignant disease with a fatal outcome, most parents are confronted with the dilemma of either accepting the inevitable death of their child or clinging to straws of hope. When approached by an investigator who suggests that there is still something that can be done in the ‘fight against the disease’ there is an opportunity to retain a glimmer of hope. No matter how impartial and accurate …
Footnotes
-
Funding None.
-
Competing interests None.
-
Provenance and peer review Commissioned; internally peer reviewed.
Linked Articles
Read the full text or download the PDF:
Other content recommended for you
- Unrealistic optimism and the ethics of phase I cancer research
- Two concepts of therapeutic optimism
- Understanding people’s ‘unrealistic optimism’ about clinical research participation
- Phase 1 oncology trials and informed consent
- Informed consent for early-phase clinical trials: therapeutic misestimation, unrealistic optimism and appreciation
- Children in health research: a matter of trust
- Why collaborate with children in health research: an analysis of the risks and benefits of collaboration with children
- Concordance and children's use of medicines
- Return of participant-level clinical trial results to participants: pilot of a simplified centralised approach
- Clinical management of stuttering in children and adults